1
|
Yadoung S, Ishimatsu R, Xu ZL, Sringarm K, Pata S, Thongkham M, Chantara S, Pattarawarapan M, Hongsibsong S. Development of IgY-Based Indirect Competitive ELISA for the Detection of Fluoroquinolone Residues in Chicken and Pork Samples. Antibiotics (Basel) 2022; 11:1512. [PMID: 36358166 PMCID: PMC9686788 DOI: 10.3390/antibiotics11111512] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2022] [Revised: 10/24/2022] [Accepted: 10/27/2022] [Indexed: 12/01/2023] Open
Abstract
Fluoroquinolones (FQs) are among the antibiotics whose widespread use in farm-raised animals results in potentially harmful residues in the end products. Additionally, most Thai farmers use antibiotics. Amoxicillin and enrofloxacin were commonly used by pig farms, and hens were given enrofloxacin to prevent immunization side effects. Moreover, antibiotic overuse has harmed food safety in the long term, and the use of low-dose antibiotics causes bacterial resistance. Herein, an indirect competitive enzyme-linked immunosorbent assay (icELISA) was used to make a fast, easy, sensitive, and cost-effective method for monitoring FQs residues. After immunizing hens with mixed multi-hapten ciprofloxacin-bovine serum albumin (CPFX-BSA) with norfloxacin-bovine serum albumin (NFX-BSA), the IgY antibody purified from egg yolk was used for the detection of FQs residues in chicken and pork samples. The efficiency of the IgY antibody showed excellent sensitivity, with 50% inhibitory concentration (IC50) of enrofloxacin at 0.05 µg/mL, far below the MRLs defined by the EU for muscle samples, which was not to exceed 100 µg/kg. The recovery range for chicken muscle samples spiked with ENFX concentrations of 1.00-0.01 µg/mL was 86.65-112.71%, similar to pork samples, which were 84.24-117.22.2%. This method has a lot of potential for analyzing fluoroquinolones in complex samples quickly, easily, and at a low cost on-site. The IgY-based ic ELISA was developed to detect ciprofloxacin (CPFX), norfloxacin (NFX), and enrofloxacin (ENFX) residues; it confirms that IgY could be a promising choice for the detection of antibiotic residues in food samples.
Collapse
Affiliation(s)
- Sumed Yadoung
- Environmental Science Program, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Ryoichi Ishimatsu
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, Motooka, Nishiku, Fukuoka 819-0395, Japan
| | - Zhen-Lin Xu
- Guangdong Provincial Key Laboratory of Food Quality and Safety, South China Agricultural University, Guangzhou 510642, China
| | - Korawan Sringarm
- Department of Animal and Aquatic Sciences, Faculty of Agriculture, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Supansa Pata
- Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Marninphan Thongkham
- Department of Animal and Aquatic Sciences, Faculty of Agriculture, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Somporn Chantara
- Environmental Science Program, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Mookda Pattarawarapan
- Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Surat Hongsibsong
- Environmental Science Program, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
- School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
| |
Collapse
|
2
|
Kumar R, Parray HA, Shrivastava T, Sinha S, Luthra K. Phage display antibody libraries: A robust approach for generation of recombinant human monoclonal antibodies. Int J Biol Macromol 2019; 135:907-918. [PMID: 31170490 DOI: 10.1016/j.ijbiomac.2019.06.006] [Citation(s) in RCA: 62] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2019] [Revised: 06/02/2019] [Accepted: 06/02/2019] [Indexed: 12/29/2022]
Abstract
Monoclonal antibodies (mAbs) and their derivatives have achieved remarkable success as medicine, targeting both diagnostic and therapeutic applications associated with communicable and non-communicable diseases. In the last 3 to 4 decades, tremendous success has been manifested in the field of cancer therapy, autoimmune diseases, cardiovascular and infectious diseases. MAbs are the fastest growing class of biopharmaceuticals, with more than 25 derivatives are in clinical use and 7 of these have been isolated through phage display technology. Phage display technology has gained impetus in the field of medical and health sciences, as a large repertoire of diverse recombinant antibodies, targeting various antigens have been generated in a short span of time. A prominent number of phage display derived antibodies are already approved for therapy and significant numbers are currently in clinical trials. In this review we have discussed the various strategies employed for generation of monoclonal antibodies; their advantages, limitations and potential therapeutic applications. We also discuss the potential of phage display antibody libraries in isolation of monoclonal antibodies.
Collapse
Affiliation(s)
- Rajesh Kumar
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India; Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001, India.
| | - Hilal Ahmed Parray
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
| | - Tripti Shrivastava
- Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001, India
| | - Subrata Sinha
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
| | - Kalpana Luthra
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
| |
Collapse
|
3
|
Grzeschik J, Yanakieva D, Roth L, Krah S, Hinz SC, Elter A, Zollmann T, Schwall G, Zielonka S, Kolmar H. Yeast Surface Display in Combination with Fluorescence‐activated Cell Sorting Enables the Rapid Isolation of Antibody Fragments Derived from Immunized Chickens. Biotechnol J 2018; 14:e1800466. [DOI: 10.1002/biot.201800466] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Revised: 10/11/2018] [Indexed: 12/13/2022]
Affiliation(s)
- Julius Grzeschik
- Institute for Organic Chemistry and BiochemistryTechnische Universität DarmstadtAlarich‐Weiss‐Strasse 4D‐64287 DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| | - Desislava Yanakieva
- Institute for Organic Chemistry and BiochemistryTechnische Universität DarmstadtAlarich‐Weiss‐Strasse 4D‐64287 DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| | - Lukas Roth
- Protein Engineering and Antibody TechnologiesMerck KGaAFrankfurter Strasse 250, D‐64293DarmstadtGermany
| | - Simon Krah
- Protein Engineering and Antibody TechnologiesMerck KGaAFrankfurter Strasse 250, D‐64293DarmstadtGermany
| | - Steffen C. Hinz
- Institute for Organic Chemistry and BiochemistryTechnische Universität DarmstadtAlarich‐Weiss‐Strasse 4D‐64287 DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| | - Adrian Elter
- Institute for Organic Chemistry and BiochemistryTechnische Universität DarmstadtAlarich‐Weiss‐Strasse 4D‐64287 DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| | - Tina Zollmann
- Science RelationsMerck KGaAFrankfurter Strasse 250, D‐64293DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| | - Gerhard Schwall
- Science RelationsMerck KGaAFrankfurter Strasse 250, D‐64293DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| | - Stefan Zielonka
- Protein Engineering and Antibody TechnologiesMerck KGaAFrankfurter Strasse 250, D‐64293DarmstadtGermany
| | - Harald Kolmar
- Institute for Organic Chemistry and BiochemistryTechnische Universität DarmstadtAlarich‐Weiss‐Strasse 4D‐64287 DarmstadtGermany
- Merck Lab @ Technische Universität DarmstadtAlarich‐Weiss‐Strasse 8, D‐64287DarmstadtGermany
| |
Collapse
|